A dual action of saturated fatty acids on electrical activity in rat pancreatic β-cells. Role of volume-regulated anion channel and KATP channel currents.
Free fatty acids (FFAs) exert complex actions on pancreatic β-cells. Typically, an initial potentiation of insulin release is followed by a gradual impairment of β-cell function, the latter effect being of possible relevance to hyperlipidaemia in type 2 diabetes mellitus. The molecular actions of FFAs are poorly understood. The present study investigated the acute effects of saturated FFAs on electrophysiological responses of rat pancreatic β-cells. Membrane potential and KATP channel activity were recorded using the perforated patch technique. Volume-regulated anion channel (VRAC) activity was assessed from conventional whole-cell recordings. Cell volume regulation was measured using a video-imaging technique. Addition of octanoate caused a transient potentiation of glucose-induced electrical activity, followed by a gradual hyper-polarisation and a prolonged inhibition of electrical activity. Octanoate caused an initial increase in VRAC activity followed by a secondary inhibition coinciding with increased KATP channel activity. Similar effects were observed with palmitate and 2-bromopalmitate whereas butyrate was virtually ineffective. Octanoate and palmitate also exerted a dual effect on electrical activity evoked by tolbutamide. Octanoate significantly attenuated cell volume regulation in hypotonic solutions, consistent with VRAC inhibition. It is concluded that medium and long chain FFAs have a dual action on glucose-induced electrical activity in rat pancreatic β-cells: an initial stimulatory effect followed by a secondary inhibition. These effects appear to be the result of reciprocal actions on VRAC and KATP channel currents, and could contribute towards the stimulatory and inhibitory actions of FFAs on pancreatic β-cell function.
Schools of Biomedicine, University of Manchester, Manchester, UK. Len.Best@cmft.nhs.uk
L
L
Best
E
E
Jarman
P D
PD
Brown
D000200:Action Potentials / Q000187:drug effects / Q000502:physiology*; D000818:Animals; D002478:Cells, Cultured; D055590:Electromagnetic Phenomena; D005227:Fatty Acids / Q000494:pharmacology* / Q000502:physiology*; D005260:Female; D057809:HEK293 Cells; D006801:Humans; D050417:Insulin-Secreting Cells / Q000187:drug effects / Q000502:physiology*; D054086:KATP Channels / Q000502:physiology*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D050994:Voltage-Dependent Anion Channels / Q000502:physiology*
D005227:Fatty Acids; D054086:KATP Channels; D050994:Voltage-Dependent Anion Channels
Mol Cell Endocrinol. 2003 Dec 30;212(1-2):1-9
14654245
Pflugers Arch. 1986;407 Suppl 2:S128-41
2434915
Biochem Pharmacol. 2009 Dec 15;78(12):1419-27
19660440
J Physiol. 1997 Mar 15;499 ( Pt 3):625-35
9130159
Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10930-4
1438299
J Biol Chem. 1998 Nov 20;273(47):31395-400
9813050
Trends Neurosci. 1991 Mar;14(3):96-100
1709540
Diabetes. 1995 Oct;44(10):1239-42
7556964
J Clin Invest. 1997 Jul 15;100(2):398-403
9218517
J Endocrinol. 2008 Sep;198(3):533-40
18550787
Islets. 2010 Nov-Dec;2(6):353-6
21099337
Biochem J. 1972 Aug;129(1):55-65
4646779
Prog Biophys Mol Biol. 1989;54(2):87-143
2484976
Mol Cell Endocrinol. 2007 Jan 15;263(1-2):173-80
17101212
Islets. 2010 Mar-Apr;2(2):59-64
21099297
Biochim Biophys Acta. 2000 Sep 29;1468(1-2):311-9
11018675
Trends Endocrinol Metab. 2003 Jul;14(5):201-3
12826323
Diabetes. 1997 Jul;46(7):1153-8
9200650
Diabetes. 1994 May;43(5):703-11
8168648
J Physiol. 2004 Jun 15;557(Pt 3):935-48
15090611
J Membr Biol. 2009 Jul;230(2):83-91
19669073
Br J Nutr. 2000 Mar;83 Suppl 1:S79-84
10889796
J Physiol. 1997 Oct 1;504 ( Pt 1):191-8
9350629
Eur J Pharmacol. 2010 Mar 10;629(1-3):159-63
20035738
Diabetes. 1998 Nov;47(11):1707-12
9792539
Diabetologia. 2008 Sep;51(9):1689-93
18622593
Endocrinology. 1993 Jul;133(1):208-14
8319569
J Endocrinol. 2002 Apr;173(1):73-80
11927386
Cell Metab. 2005 Apr;1(4):245-58
16054069
FEBS Lett. 1990 Feb 12;261(1):187-90
2407553
Am J Physiol. 1994 Apr;266(4 Pt 1):E635-9
8178984
J Physiol. 1992 Oct;456:351-71
1284079
Diabetes. 2006 Dec;55 Suppl 2:S16-23
17130640
Acta Physiol (Oxf). 2006 May-Jun;187(1-2):295-303
16734766
Proc Natl Acad Sci U S A. 1990 Sep;87(18):7334-8
1698296
Eur J Pharmacol. 2004 Apr 5;489(1-2):13-9
15063150
FEBS Lett. 1972 Feb 1;20(2):225-228
11946423
Metabolism. 2003 Oct;52(10):1367-71
14564691
Diabetologia. 1997 Sep;40(9):1018-27
9300238
Acta Physiol (Oxf). 2006 May-Jun;187(1-2):285-94
16734765
Proc Natl Acad Sci U S A. 1990 Aug;87(15):5706-9
1696009
Biochim Biophys Acta. 1969 Sep 2;184(3):540-53
5821020
Biochem Med Metab Biol. 1994 Apr;51(2):175-84
8043302
Biochem Biophys Res Commun. 2005 Sep 16;335(1):97-104
16081037
J Clin Invest. 1969 Oct;48(10):1934-43
5822597
Diabetologia. 2004 Feb;47(2):277-83
14740158
J Gen Physiol. 2000 Apr;115(4):405-16
10736308
J Physiol. 2005 Oct 1;568(Pt 1):137-44
16024506
J Lab Clin Med. 1968 Sep;72(3):438-48
5674075
J Clin Invest. 1994 Feb;93(2):870-6
8113418
Endocrinology. 1990 Oct;127(4):1580-9
1698143
Diabetes. 2002 Feb;51 Suppl 1:S134-7
11815472
Mol Cell Endocrinol. 1999 Jul 20;153(1-2):147-53
10459862
Nature. 2003 Mar 13;422(6928):173-6
12629551
Pflugers Arch. 1996 Jan;431(3):363-70
8584429